SONIA HERNANDEZ: Open Payments
NPI 1922500891 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,031 in 154 payments from 43 companies in 2025. Trend: 2023 $3,494 · 2024 $3,807 · 2025 $4,031
Food & beverage: $3,662Education: $368
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $459 |
| AstraZeneca Pharmaceuticals LP | 12 | $328 |
| Janssen Biotech, Inc. | 14 | $323 |
| Merck Sharp & Dohme LLC | 11 | $303 |
| GlaxoSmithKline, LLC. | 10 | $249 |
| SOBI, INC | 5 | $227 |
| Incyte Corporation | 4 | $156 |
| Celgene Corporation | 6 | $154 |
| Eisai Inc. | 5 | $136 |
| ABBVIE INC. | 5 | $112 |
Products named: KEYTRUDA, ENHERTU, KISQALI, Fabhalta, Lenvima, VENCLEXTA, Vonjo, JEMPERLI.
Industry payments across TX — which companies pay providers there.
